Abiopharma

🔍 Ho Kok Kyu (Executive)

Company: DDC Enterprise Ltd (DDC)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 280,000 shares of Class A Ordinary Shares (Warrants) at $0.16 per share (Direct)
  Date: 2026-04-28 | Code: X | equity_swap_involved: 0 | shares_owned_after: 566,547.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Class A Ordinary Shares (Restricted Stock Units) (Direct)
  Date: 2026-03-20 | Code: H | shares_owned_after: 103,042.00
• Sold 300,000 shares of Warrants at $0.16 per share (Derivative)
  Date: 2026-04-28 | Code: X | Expires: 2035-12-30 | Exercise: 2026-03-16 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Holds 67,566 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | Exercise: 2025-04-21 | shares_owned_after: 67,566.00 | Footnotes: F2, F2
• Holds 437,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | Exercise: 2025-07-01 | shares_owned_after: 437,500.00 | Footnotes: F2, F2
• Holds 813,008 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | Exercise: 2025-12-13 | shares_owned_after: 813,008.00 | Footnotes: F2, F2

Footnotes:

• F1: On April 28, 2026, the reporting person exercised an aggregate of 300,000 warrants pursuant to the exercise notice at the exercise price of $0.16 per share. The reporting person elected to satisfy the aggregate exercise price through a cashless exercise, pursuant to which a net of 280,000 Class A Ordinary Shares was issued to the reporting person.
• F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Ordinary Shares, subject to time based vesting and the terms of the applicable award agreement. Each RSU has no expiration date and carries a zero exercise price.